These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38189503)

  • 1. Atrial fibrillation therapy and stroke prevention in hemodialysis patients.
    Melenovský V; Osmančík P
    Kardiol Pol; 2023; 81(12):1193-1204. PubMed ID: 38189503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.
    Kimachi M; Furukawa TA; Kimachi K; Goto Y; Fukuma S; Fukuhara S
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011373. PubMed ID: 29105079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
    Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
    Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonvalvular atrial fibrillation in patients undergoing chronic hemodialysis. Should dialysis patients with atrial fibrillation receive oral anticoagulation?
    Sánchez-González C; Herrero Calvo JA
    Nefrologia (Engl Ed); 2022; 42(6):633-644. PubMed ID: 36907719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Anticoagulant Agents in Patients With Atrial Fibrillation and CKD: A Systematic Review and Pairwise Network Meta-analysis.
    Su X; Yan B; Wang L; Lv J; Cheng H; Chen Y
    Am J Kidney Dis; 2021 Nov; 78(5):678-689.e1. PubMed ID: 33872690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-thrombotic therapy for atrial fibrillation in patients with chronic kidney disease: Current views.
    Ghadban R; Flaker G; Katta N; Alpert MA
    Hemodial Int; 2017 Oct; 21 Suppl 2():S47-S56. PubMed ID: 29064182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report.
    Bansal VK; Herzog CA; Sarnak MJ; Choi MJ; Mehta R; Jaar BG; Rocco MV; Kramer H
    Am J Kidney Dis; 2017 Dec; 70(6):859-868. PubMed ID: 28941763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation].
    Di Lullo L; Barbera V; Bellasi A; Cozzolino M; Russo D; Otranto G; Santoboni F; Ronco C
    G Ital Nefrol; 2017 Apr; 34(2):58-73. PubMed ID: 28682563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease.
    Potpara TS; Jokic V; Dagres N; Larsen TB; Lane DA; Hindricks G; Lip GY
    Curr Med Chem; 2016; 23(19):2055-69. PubMed ID: 26861000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of patients with atrial fibrillation and chronic kidney disease in light of the latest guidelines.
    Młodawska E; Tomaszuk-Kazberuk A; Łopatowska P; Musiał WJ; Małyszko J
    Pol Arch Med Wewn; 2016 May; 126(5):353-62. PubMed ID: 27243343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
    Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A
    Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
    Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation management in haemodialysis patients with atrial fibrillation: evidence and opinion.
    De Vriese AS; Heine G
    Nephrol Dial Transplant; 2022 Oct; 37(11):2072-2079. PubMed ID: 33647941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation.
    Feldberg J; Patel P; Farrell A; Sivarajahkumar S; Cameron K; Ma J; Battistella M
    Nephrol Dial Transplant; 2019 Feb; 34(2):265-277. PubMed ID: 29509922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of vitamin K-antagonists (VKA) for atrial fibrillation in non-dialysis dependent chronic kidney disease.
    Kooiman J; van Rein N; Spaans B; van Beers KA; Bank JR; van de Peppel WR; del Sol AI; Cannegieter SC; Rabelink TJ; Lip GY; Klok FA; Huisman MV
    PLoS One; 2014; 9(5):e94420. PubMed ID: 24817475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants.
    Trevisan M; Hjemdahl P; Clase CM; de Jong Y; Evans M; Bellocco R; Fu EL; Carrero JJ
    Am J Kidney Dis; 2023 Mar; 81(3):307-317.e1. PubMed ID: 36208798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial.
    Pokorney SD; Chertow GM; Al-Khalidi HR; Gallup D; Dignacco P; Mussina K; Bansal N; Gadegbeku CA; Garcia DA; Garonzik S; Lopes RD; Mahaffey KW; Matsuda K; Middleton JP; Rymer JA; Sands GH; Thadhani R; Thomas KL; Washam JB; Winkelmayer WC; Granger CB;
    Circulation; 2022 Dec; 146(23):1735-1745. PubMed ID: 36335914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis.
    Van Der Meersch H; De Bacquer D; De Vriese AS
    Am Heart J; 2017 Feb; 184():37-46. PubMed ID: 27892885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which anticoagulants should be used for stroke prevention in non-valvular atrial fibrillation and severe chronic kidney disease?
    Kalra PA; Burlacu A; Ferro CJ; Covic A
    Curr Opin Nephrol Hypertens; 2018 Nov; 27(6):420-425. PubMed ID: 30020140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.